Access cutting-edge alveolar soft part sarcoma treatment through this clinical trial at a research site in Hartford. Study-provided care at no cost to qualified participants.
Access alveolar soft part sarcoma specialists in Hartford at no cost
This study follows strict safety protocols and ethical guidelines
All study-related alveolar soft part sarcoma treatment provided free
This phase II trial tests whether atezolizumab in combination with selinexor works to shrink tumors in patients with alveolar soft part sarcoma and whether the study drugs are better than the usual approach in treating this type of cancer. The usual approach is defined as care most people get for alveolar soft part sarcoma if they are not part of a clinical study, which includes treatment with radiation, kinase inhibitor drugs, immunotherapy drugs, or chemotherapy drugs. Immunotherapy with monoc
Sponsor: National Cancer Institute (NCI)
Check if you qualify for this alveolar soft part sarcoma clinical trial in Hartford, CT
If you're searching for alveolar soft part sarcoma treatment options in Hartford, CT, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Hartford research site is actively enrolling participants for this clinical trial. You'll receive care from experienced alveolar soft part sarcoma specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.